Show simple item record

dc.contributor.authorWang, Yifei
dc.contributor.authorSedlacek, Abigail L.
dc.contributor.authorPawaria, Sudesh
dc.contributor.authorXu, Haiyan
dc.contributor.authorScott, Melanie J.
dc.contributor.authorBinder, Robert J.
dc.date2022-08-11T08:09:51.000
dc.date.accessioned2022-08-23T16:46:00Z
dc.date.available2022-08-23T16:46:00Z
dc.date.issued2018-10-15
dc.date.submitted2018-11-14
dc.identifier.citation<p>J Immunol. 2018 Oct 15;201(8):2209-2214. doi: 10.4049/jimmunol.1800505. Epub 2018 Sep 12. <a href="https://doi.org/10.4049/jimmunol.1800505">Link to article on publisher's site</a></p>
dc.identifier.issn0022-1767 (Linking)
dc.identifier.doi10.4049/jimmunol.1800505
dc.identifier.pmid30209191
dc.identifier.urihttp://hdl.handle.net/20.500.14038/40795
dc.description.abstractSeveral heat shock proteins (HSPs) prime immune responses, which are, in part, a result of activation of APCs. APCs respond to these immunogenic HSPs by upregulating costimulatory molecules and secreting cytokines, including IL-1beta. These HSP-mediated responses are central mediators in pathological conditions ranging from cancer, sterile inflammation associated with trauma, and rheumatoid arthritis. We tested in this study the requirement of inflammasomes in the release of IL-1beta by one immunogenic HSP, gp96. Our results show that murine APCs activate NLRP3 inflammasomes in response to gp96 by K(+) efflux. This is shown to initiate inflammatory conditions in vivo in the absence of additional known inflammasome activators or infection. These results document a novel mechanism by which proteins of endogenous origin, the HSPs, can modulate an inflammatory response following their release from aberrant cells.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=30209191&dopt=Abstract">Link to Article in PubMed</a></p>
dc.rightsCopyright © 2018 by The American Association of Immunologists, Inc. Publisher's PDF posted as allowed by publisher's Author Choice policy at: http://www.jimmunol.org/info/authorchoice.
dc.subjectheat shock proteins
dc.subjectimmune responses
dc.subjectcytokines
dc.subjectImmunology and Infectious Disease
dc.titleCutting Edge: The Heat Shock Protein gp96 Activates Inflammasome-Signaling Platforms in APCs
dc.typeJournal Article
dc.source.journaltitleJournal of immunology (Baltimore, Md. : 1950)
dc.source.volume201
dc.source.issue8
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=4615&amp;context=oapubs&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/oapubs/3603
dc.identifier.contextkey13312407
refterms.dateFOA2022-08-23T16:46:01Z
html.description.abstract<p>Several heat shock proteins (HSPs) prime immune responses, which are, in part, a result of activation of APCs. APCs respond to these immunogenic HSPs by upregulating costimulatory molecules and secreting cytokines, including IL-1beta. These HSP-mediated responses are central mediators in pathological conditions ranging from cancer, sterile inflammation associated with trauma, and rheumatoid arthritis. We tested in this study the requirement of inflammasomes in the release of IL-1beta by one immunogenic HSP, gp96. Our results show that murine APCs activate NLRP3 inflammasomes in response to gp96 by K(+) efflux. This is shown to initiate inflammatory conditions in vivo in the absence of additional known inflammasome activators or infection. These results document a novel mechanism by which proteins of endogenous origin, the HSPs, can modulate an inflammatory response following their release from aberrant cells.</p>
dc.identifier.submissionpathoapubs/3603
dc.contributor.departmentDepartment of Medicine
dc.source.pages2209-2214


Files in this item

Thumbnail
Name:
2209.full.pdf
Size:
1.679Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record